Trials / Completed
CompletedNCT02245997
Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 78 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 12 Months – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to give 12T a smaller dose of radiation in order to decrease these late side effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | External beam radiotherapy | |
| RADIATION | proton beam RT |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2025-05-01
- Completion
- 2025-05-01
- First posted
- 2014-09-22
- Last updated
- 2025-09-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02245997. Inclusion in this directory is not an endorsement.